Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Classifica tra le azioni #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Prezzo delle azioni
$0.88
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$10.41M
Variazione (1 giorno)
-7.26%
Variazione (1 anno)
-50.56%
Paese
SG
Scambia CytoMed Therapeutics Limited (GDTC)

Categoria

Il prezzo GDTC con la capitalizzazione del mercato della B
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
GDTC
$0.88
Capitalizzazione di mercato di CytoMed Therapeutics Limited(GDTC)
Capitalizzazione di mercato: $10.41M
A partire dal August 2026, CytoMed Therapeutics Limited ha una capitalizzazione di mercato pari a $10.41M. Questo rende CytoMed Therapeutics Limited la 32327th azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di CytoMed Therapeutics Limited dal 2023 al 2026
GDTC in paragone con la classifica dei più popolari stocks
Il prezzo per GDTC Attivo B Capitalizzazione del mercato a B Risultati
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
$461,440 $10.41M
$5.460T +52,436,229.74%
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
$379,409 $10.41M
$4.489T +43,114,559.23%
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
$349,949 $10.41M
$4.141T +39,766,855.83%
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
$301,579 $10.41M
$3.569T +34,270,233.57%
CytoMed Therapeutics Limited CytoMed Therapeutics Limited
$236,463 $10.41M
$2.798T +26,870,711.00%